IntrinsicIntrinsic
OverviewFinancialsChartBusiness SummaryFilingsOwnershipValuation

Financial Statements — ECG

Balance Sheet

(in billions USD)
MetricQ1 2026Q3 2025Q2 2025Q1 2025Q3 2024
Cash & Equivalents0.290.150.080.070.00
Accounts Receivable0.780.740.680.59--
Inventory0.050.050.050.050.05
Total Current Assets1.421.221.090.970.89
Property, Plant & Equipment0.170.150.150.150.13
Goodwill0.140.140.140.140.14
Intangible Assets0.000.000.000.000.00
Total Non-current Assets0.430.410.390.380.39
Total Assets1.851.621.481.361.28
Accounts Payable0.260.210.200.180.16
Total Current Liabilities0.800.690.610.550.56
Long-term Debt0.280.290.290.290.21
Total Non-current Liabilities0.360.360.350.350.27
Total Liabilities1.161.050.970.900.83
Retained Earnings0.540.430.370.320.32
Total Stockholder Equity0.690.570.510.460.45

Income Statement

(in billions USD) (except per-share rows)
MetricQ1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total Revenue1.041.010.990.920.830.760.76
Cost of Revenue0.910.890.860.800.730.670.67
Gross Profit0.130.120.120.120.090.090.09
Selling, General & Admin0.050.050.050.050.040.040.02
Total Operating Expenses0.050.050.050.050.040.040.04
Operating Income0.080.070.070.070.050.050.05
Pretax Income0.080.070.070.070.050.040.05
Tax Provision0.020.020.020.020.010.010.01
Net Income0.060.060.060.050.040.030.04
Basic EPS1.141.071.121.040.720.670.82
Diluted EPS1.141.091.111.030.720.670.82

Cash Flow Statement

(in millions USD)
MetricQ1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Operating Cash Flow143.6848.2176.1725.347.1380.6982.68
Capital Expenditures15.4724.7210.5013.0818.5413.7734.51
Free Cash Flow*128.2123.4965.6712.26(11.41)66.9248.18
Investing Cash Flow(14.30)(23.12)(7.96)(10.86)(14.82)(11.57)(25.49)
Financing Cash Flow(6.52)(3.75)(3.75)(3.75)(4.34)16.34(58.21)

* Derived from reported values